← Back to Patent Explorer
US6032674A Expired / Lapsed US ⏱️ 0.0 years remaining

Systems and methods for myocardial revascularization

Assignee: Arthrocare Corp
•
Filing: 1997-12-31
•
Granted: 2000-03-07
•
Expires: 2017-12-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for transmyocardial revascularization of the heart of a patient includes positioning an active electrode surface in close proximity to a target site on the wall of a patient's heart, and applying high frequency voltage between the active voltage surface and a return electrode to ablate tissue at the heart wall. The high frequency voltage ablates, i.e. volumetrically removes the heart tissue, and the electrode surface is axially translated into the space vacated by the removed tissue to bore a channel through the heart tissue. The active electrode surface may be introduced into the thoracic cavity and placed adjacent the epicardium to form an inward channel toward the ventricular cavity, or it may be delivered into the ventricular cavity of the heart and positioned adjacent the endocardium to form a channel extending outward towards the epicardium. In either case, the channels formed through the myocardium promote direct communication between blood within the ventricular cavity and that of existing myocardial vasculature to increase blood flow to the heart tissue.

Inventors

  • 👤 Philip E. Eggers
  • 👤 Hira V. Thapliyal

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:02
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/04; A61B18/12; A61B18/14; A61B18/1492; A61B18/1206; A61B18/1402; A61B18/148; A61B18/1482; A61B18/1485; A61B18/149; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2493; A61M; A61M25/00; A61M25/01; A61M25/0105; A61M25/0133; A61B17/00; A61B2017/00017; A61B2017/00022; A61B2017/00026; A61B2017/00084; A61B2017/00092; A61B2017/00097; A61B2017/00101; A61B2017/00106; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/00292; A61B2017/003; A61B17/22; A61B2017/22001; A61B2017/22038; A61B2018/00005; A61B2018/00011; A61B2018/00029; A61B2018/00053; A61B2018/00059; A61B2018/00071; A61B2018/00083; A61B2018/00107; A61B2018/00119; A61B2018/0016; A61B2018/00172; A61B2018/00178; A61B2018/00184; A61B2018/00196; A61B2018/00315; A61B2018/00321; A61B2018/00327; A61B2018/00345; A61B2018/00351; A61B2018/00392; A61B2018/00505; A61B2018/00571; A61B2018/00577; A61B2018/00583; A61B2018/00601; A61B2018/00636; A61B2018/00642; A61B2018/0066; A61B2018/00666; A61B2018/00678; A61B2018/00696; A61B2018/00702; A61B2018/00726; A61B2018/00738; A61B2018/00755; A61B2018/00761; A61B2018/00773; A61B2018/00791; A61B2018/00797; A61B2018/00821; A61B2018/00827; A61B2018/00875; A61B2018/00886; A61B2018/00982; A61B2018/1213; A61B2018/124; A61B2018/1246; A61B2018/1253; A61B2018/126; A61B2018/1273; A61B2018/1405; A61B2018/1407; A61B2018/1467; A61B2018/1472; A61B2018/1497; A61B18/16; A61B2018/162; A61B2018/165; A61B90/00; A61B90/36; A61B90/37; A61B2090/378; A61B2090/3782; A61B2218/00; A61B2218/001; A61B2218/002; A61B2218/007; A61F2/95; A61M25/0147; A61M25/0158

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 62 words
A method of treating a patient's heart comprising: positioning an active electrode surface in close proximity to a target site on a wall of the patient's heart; applying high frequency voltage between the active electrode surface and a return electrode to form a revascularizing channel through at least a portion of the heart wall; and controlling the depth of the revascularizing channel.
Claim 2
Independent Claim 62 words
A method of treating a patient's heart comprising: positioning an active electrode surface in close proximity to a target site on a wall of the patient's heart; applying high frequency voltage between the active electrode surface and a return electrode to form a revascularizing channel through at least a portion of the heart wall; and controlling the depth of the revascularizing channel.
Claim 3
Dependent Claim 16 words
The method of claim 1 further comprising visually marking the target site on the heart wall.
Claim 4
Dependent Claim 18 words
The method of claim 1 further comprising determining a thickness of the heart wall at the target site.
Claim 5
Dependent Claim 47 words
The method of claim 3 further comprising setting a predetermined distance through the heart wall at the target site and interrupting the flow of voltage to the active electrode surface when said active electrode surface has advanced the predetermined distance to control the depth of the channel.
Claim 6
Dependent Claim 22 words
The method of claim 4 wherein the determining step comprises measuring tissue impedance beyond the distal end of the active electrode surface.
Claim 7
Dependent Claim 23 words
The method of claim 1 further comprising the step of determining when the active electrode surface has substantially penetrated through the heart wall.
Claim 8
Dependent Claim 26 words
The method of claim 6 further comprising terminating the high frequency voltage before the active electrode surface pierces an opposite wall surface of the heart wall.
Claim 9
Dependent Claim 21 words
The method of claim 1 further comprising delivering ultrasound signals onto the heart wall to control the depth of the channel.
Claim 10
Independent Claim 64 words
A method of treating a patient's heart comprising: positioning a channel forming device in close proximity to a target site on a wall of the patient's epicardium; applying energy to the channel forming device to form a revascularizing channel through at least a portion of the heart wall; and sealing the revascularizing channel at the epicardium to inhibit blood flow into the thoracic cavity.
Claim 11
Independent Claim 64 words
A method of treating a patient's heart comprising: positioning a channel forming device in close proximity to a target site on a wall of the patient's epicardium; applying energy to the channel forming device to form a revascularizing channel through at least a portion of the heart wall; and sealing the revascularizing channel at the epicardium to inhibit blood flow into the thoracic cavity.
Claim 12
Dependent Claim 32 words
The method of claim 9 wherein the sealing step includes delivering collagen to the channel at the epicardium to form a plug near the surface of the epicardium and the revascularizing channel.
Claim 13
Dependent Claim 46 words
The method of claim 10 wherein the channel forming element comprises an active electrode, and the applying energy step comprises applying high frequency voltage between the active electrode and a return electrode to form the revascularizing channel through at least a portion of the heart wall.

References Cited (Backward Citations)

US4033351A Cited
US4043342A Cited
US4116198A Cited
US4040426A Cited
US4202337A Cited
US4228800A Cited
US4326529A Cited
US4232676A Cited
US4248231A Cited
US4532924A Cited
US4476862A Cited
US4674499A Cited
US4381007A Cited
US4548207A Cited
US4593691A Cited
US4567890A Cited
US4682596A Cited
US4706667A Cited
RU2026640C1 Cited
US4658817A Cited
US4785815A Cited
US4765331A Cited
US4823791A Cited
US4936301A Cited
US4943290A Cited
US4931047A Cited
US5108391A Cited
US5178620A Cited
US4998933A Cited
US4955377A Cited
US4966597A Cited
US5370644A Cited
US5246438A Cited
US5454809A Cited
US5078717A Cited
US5098431A Cited
US4979948A Cited
US5125928A Cited
US4976711A Cited
US5009656A Cited
US5007908A Cited
US5217457A Cited
US5078736A Cited
US5380277A Cited
US5083565A Cited
US5125924A Cited
US5122138A Cited
US5380316A Cited
US5554152A Cited
US5389096A Cited
US5267997A Cited
US5279299A Cited
US5156151A Cited
EP0515867B1 Cited
US5607421A Cited
US5330496A Cited
US5195959A Cited
US5190517A Cited
US5330470A Cited
US5383917A Cited
US5697281A Cited
US5395312A Cited
US5197963A Cited
US5873855A Cited
US5683366A Cited
US5697909A Cited
US5810764A Cited
US5366443A Cited
US5860951A Cited
US5697882A Cited
US5681282A Cited
US5697536A Cited
US5419767A Cited
US5843019A Cited
US5267994A Cited
US5281216A Cited
US5318525A Cited
US5277201A Cited
US5281218A Cited
US5293868A Cited
US5500012A Cited
US5370675A Cited
US5300069A Cited
US5312400A Cited
US5314406A Cited
US5584872A Cited
US5437662A Cited
US5342357A Cited
US5676693A Cited
US5545161A Cited
US5335668A Cited
US5417687A Cited
US5766153A Cited
US5860974A Cited
US5807395A Cited
US5487385A Cited
US5569242A Cited
US5681308A Cited
US5647869A Cited
US5885277A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-03-07 2003-09-06 2004-03-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-03-07 2007-09-06 2008-03-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-03-07 2011-09-06 2012-03-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag